The US House of Representatives approved of a $3.2 billion budget for the FDA for the 2021 fiscal year, a $40.8 million increase from the 2020 fiscal year. The additional funding is meant to support new initiatives for greater collaboration across departments within the FDA, as well as help expedite a faster approval process, all while promoting greater safety for drug development, medical devices, and food. The bill now moves on for approval from the US Senate. 

Read more here

More on: